{{knowledge objective
|Identifiant=OIC-258-04-A
|Item_parent=Elevation of creatininemia
|Item_parent_short=Elevation of creatininaemia
|Rank=A
|Title=Cite the circumstances in which creatinemia should be measured
|Description=None
|Heading=Management
|Contributors=Vrtovsnik,Flamant,Frimat
|Order=4}}

[178 Circumstances in which creatinine should be measured according to the French National Authority for Health (Haute Autorité de Santé)
{| class="wikitable"
|
|Diabetes, hypertension whether treated or not, age > 60 years; obesity (BMI > 30 kg/m2) ;

Atheromatous cardiovascular disease, heart failure ;

Systemic or autoimmune diseases (lupus, vasculitis, rheumatoid arthritis);

Urinary tract abnormality, urological disease (obstructive uropathy, recurrent urinary tract infections, etc.)

History of acute renal failure; family history of renal disease

Exposure to occupational toxins (lead, cadmium, mercury); previous nephrotoxic treatment (NSAIDs, exposure to iodinated contrast media, chemotherapy, radiotherapy, etc.).
|}